These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 5780119)

  • 1. [Specific inhibitors of the interaction of some serum proteins in malignant tumors. 3. Demonstration of the neutralizing effect of the non-hemoglobin fraction of erythrocytes on the inhibitors of sera from patients with tumors and its isolation].
    Suchan M
    Cas Lek Cesk; 1969 Jan; 108(3):81-4. PubMed ID: 5780119
    [No Abstract]   [Full Text] [Related]  

  • 2. [Specific inhibitory interactions of serum proteins in malignant tumors. I. Study of the relations and properties of active serum inhibitors].
    Suchan M
    Cas Lek Cesk; 1967 Dec; 106(49):1323-7. PubMed ID: 5595102
    [No Abstract]   [Full Text] [Related]  

  • 3. [Proteolytic enzymes and their inhibitors in the tumors and blood serum of patients with breast neoplasms].
    Blizniuk BF
    Vopr Med Khim; 1982; 28(4):123-6. PubMed ID: 7051547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of thyroid hormone and hemoglobin. I. Nature of the interaction and effect of hemoglobin on thyroid hormone radioimmunoassay.
    Davis PJ; Yoshida K; Schoenl M
    J Lab Clin Med; 1980 May; 95(5):714-24. PubMed ID: 7365316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Titration of serum p53 antibodies in 1,085 patients with various types of malignant tumors: a multiinstitutional analysis by the Japan p53 Antibody Research Group.
    Shimada H; Ochiai T; Nomura F;
    Cancer; 2003 Feb; 97(3):682-9. PubMed ID: 12548611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of serotonin and tryptophan on the blood picture and on tryptophan in the serum proteins in leukopenia in patients with malignant neoplasms].
    Rudzit VK
    Klin Lech Zlokach Novoobraz; 1968; 11():117-24. PubMed ID: 5725401
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comparative serum protein studies with the ultracentrifuge and paper electrophoresis in malignant tumors].
    KOCH D; ODENTHAL H; BERTHEAU K
    Dtsch Arch Klin Med; 1957; 204(3):252-64. PubMed ID: 13490116
    [No Abstract]   [Full Text] [Related]  

  • 8. Hematological malignancies are associated with a lower interferon-a blocking activity than solid tumors.
    Karmaniolas K; Dalamaga M; Liatis S; Kaskara A; Rigopoulos A; Migdalis IN
    Res Commun Mol Pathol Pharmacol; 2005; 117-118():65-75. PubMed ID: 18426079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Polysaccharides & mucoproteins in erythrocytes in carcinosis & non-carcinosis; preliminary report].
    OLBERT T
    Krebsarzt; 1957 Oct; 12(5):272-4. PubMed ID: 13476632
    [No Abstract]   [Full Text] [Related]  

  • 10. [Changes in blood mucoproteins levels in patients with malignant tumors].
    MEEROFF M
    Sem Med; 1958 Jul; 113(2):60-104. PubMed ID: 13592366
    [No Abstract]   [Full Text] [Related]  

  • 11. Quantitative and qualitative changes in serum oligopeptide components of patients with end stage malignant tumour disease.
    Ribai Z; Vallent K; Gróf J; Menyhárt J; Idei M
    Acta Physiol Acad Sci Hung; 1982; 60(3):129-34. PubMed ID: 7185253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of the O6-methylguanine-DNA methyltransferase and glutathione S-transferase activity in the sera of patients with malignant and benign ovarian tumors.
    Akçay T; Dinçer Y; Alademir Z; Aydinli K; Arvas M; Demirkiran F; Kösebay D
    Eur J Obstet Gynecol Reprod Biol; 2005 Mar; 119(1):108-13. PubMed ID: 15734094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of a serum DNA-binding protein associated with cancer.
    Galvan L; Evans JE; Comis RL; Gottlieb A; Gyorkey F; Lane M; Prestayko AW; Crooke ST
    Cancer Res; 1982 Apr; 42(4):1562-6. PubMed ID: 6174228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study of serum levels of magnesium in the patients with malignant tumors].
    Varazashvili Varazi LM; Osmanova VR; Barkadze KI
    Georgian Med News; 2006 Jul; (136):35-9. PubMed ID: 16905841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum haptoglobin, CA 125 and interleukin 6 levels in malignant and non-malignant tumors of the ovary.
    Dobryszycka W; Katnik-Prastowska I; Gerber J; Lemańska K; Utko K; Rozdolski K
    Arch Immunol Ther Exp (Warsz); 1999; 47(4):229-36. PubMed ID: 10483871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased levels of a 21-kDa protein in the circulation of tumor-bearing patients.
    Shalitin C; Epelbaum R; Moskovitz B; Segal R; Valansi C; Werner M; Livne PM
    Cancer Detect Prev; 1994; 18(5):357-65. PubMed ID: 7812982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 67Gallium kinetics in the blood of patients with malignant tumors.
    Keller F; Maiga MK; Koeppe P
    Nuklearmedizin; 1983 Jun; 22(3):155-8. PubMed ID: 6578495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [On electrophoretic changes in proteins and lipoproteins in the blood serum in malignant neoplasms].
    ATAMANOV GS; SAPEROV VN
    Sov Med; 1961 May; 25():80-6. PubMed ID: 13684929
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of irradiation on blood proteins in rats with benzopyrene tumors].
    VERGA V; GIORDANO G
    Boll Soc Ital Biol Sper; 1954 Jun; 30(6):614-5. PubMed ID: 14351376
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical significance of protein Z detection in patients with malignant tumors].
    Shang Y; Pan XY; Ding CP; Yang XM; Cai XY; Ding Y; Zhang RL
    Ai Zheng; 2005 Sep; 24(9):1144-7. PubMed ID: 16159443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.